Publication | Closed Access
Pharmacokinetics of fosfomycin in hemodialyzed patients.
15
Citations
0
References
1985
Year
Dialysis TherapyPharmacotherapyAntimicrobial ChemotherapyPharmacokineticsDrug ResistanceHemodialyzed PatientsPlasma LevelsBioanalysisAntimicrobial ResistanceTherapeutic Drug MonitoringPharmacokinetic ModelingDialysis SessionsAntimicrobial PharmacokineticsPharmacologyAntimicrobial SusceptibilityAntibioticsHemodialyzer 103Antimicrobial PharmacodynamicsMedicineNephrology
The pharmacokinetics of fosfomycin, an original antimicrobial agent, were investigated in 11 voluntary hemodialyzed patients. Fosfomycin, 2 g, was administered intravenously, 15 minutes before hemodialysis began in group 1 (6 patients), and just after hemodialysis in group 2 (6 patients). Blood samples were collected during 8 hours (group 1) and during 44 hours (group 2). Antibiotic concentrations were determined microbiologically. In group 1, half-life was 4.2 +/- 0.27 hours, total clearance 65.1 +/- 7.1 ml/mn and clearance by hemodialyzer 103 +/- 10 ml/mn. In group 2 plasma levels were 60 mg/l at the 44th hour and half-life was 48.8 +/- 17.5 hours. These results suggest that fosfomycin is actively eliminated by the hemodialyzer in group 1, and largely retained between two dialysis sessions in group 2. As for therapy, intravenous administration of 2 g after dialysis and further administration after each succeeding session are proposed.